Upregulation and interaction of TNFα and gelatinases A and B in painful peripheral nerve injury

Brain Research

Volumn 855, Issue 1, 2000, Pages 83-89

  Shubayev, Veronica I ^a   Myers, Robert R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Axonal injury; Matrix metalloproteinase; TNF receptor I; TNF ; Wallerian degeneration

Indexed keywords

GELATINASE A; GELATINASE B; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ASSAY; IMMUNOBLOTTING; MACROPHAGE; MALE; MAST CELL; NERVE DEGENERATION; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FAMILY; RAT; SCHWANN CELL; SCIATIC NERVE; ANIMAL; CHEMISTRY; ENZYMOLOGY; IMMUNOLOGY; INJURY; ISCHIALGIA; METABOLISM; NERVE FIBER; PERIPHERAL NERVE; SCIATIC NEUROPATHY; SPRAGUE DAWLEY RAT;

ANIMALS; AXONS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PERIPHERAL NERVES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TUMOR NECROSIS FACTOR; SCIATIC NERVE; SCIATIC NEUROPATHY; SCIATICA; TUMOR NECROSIS FACTOR-ALPHA; WALLERIAN DEGENERATION;

EID: 0033621668     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02321-5     Document Type: Article

References (34)

1. Bemelmans M.H.A., Van Tits L.J.H., Buurman W.A. Tumor necrosis factor: functions, release and clearance. Crit. Rev. Immunol. 16:1996;1-11.
2. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensations like those seen in man. Pain. 33:1988;498-562.
3. Birkedal-Hansen H., Moore W.G.I., Bodden M.K., Windsor L.J., Birkedal-Hansen B., DeCarlo A., Engler J.A. Matrix metalloproteinases: a review. Clin. Rev. Oral Biol. Med. 4(2):1993;197-250.
4. Black R.A., Rauch C.T., Kozlovsky C.J., Peschon J.J., Slack J.L., Wolfson M.F., Castner B.J., Stocking K.L., Reddy P., Srinivasan S., Nelson N., Boiani N., Schooley K.A., Gerhart M., Davis R., Fitzner J.N., Johnson R.S., Paxton R.J., March C.J., Cerretti D.P. A metalloproteinase disintegrin that releases tumor necrosis factor-α from cells. Nature. 385:1997;729-732.
5. Chandler S., Miller K.M., Clements J.M., Lury J., Corkill D., Anthony D.C.C., Adams S.E., Gearing A.J.H. Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview. J. Neuroimmunol. 72(2):1997;155-161.
6. Darnay B.G., Aggarwal B.B. Early events in TNF signaling: a story of associations and dissociations. J. Leukocyte Biol. 61:1997;559-566.
7. Feuerstein G.Z., Liu T., Barone F.C. Cytokines, inflammation and brain injury: role of tumor necrosis factor-alpha. Cerebrovasc. Brain Metab. Rev. 6(4):1994;341-360.
8. Gearing A.J.H., Beckett P., Christodoulou M., Churchill M., Clements J., Davidson A.H., Drummond A.H., Galloway W.A., Gilbert R., Gordon J.L., Leber T.M., Mangan M., Miller K., Nayee P., Owen K., Patel S., Thomas W., Wells G., Wood L.M., Woolley K. Processing of TNFα precursor by metalloproteinases. Nature. 370:1994;555-557.
9. Glaser K.B., Pease L., Li J., Morgan D.W. Enhancement of the surface expression of TNF but not the p55 TNF receptor in the TH-1 monocytic cell line by matrix metalloprotease inhibitor. Biochem. Pharmacol. 57(3):1999;291-302.
10. J.W. Griffin, P.N. Hoffman, Degeneration and regeneration in the peripheral nervous system, in: Dyck (Eds.), Peripheral Neuropathy: Development and Regeneration of the Peripheral Nervous System, Vol. 2, Saunders, 1993, pp. 361-376.
11. Herron G.S., Werb Z., Dwyer K., Banda M.J. Secretion of metallo-proteinases by stimulated capillary endothelial cells. J. Biol. Chem. 261:1986;2810-2813.
12. Hibbs M.S., Hasty K.A., Seyer J.M., Kang A.H., Mainardi C.L. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J. Biol. Chem. 260:1985;2493-2500.
13. Hooper N.M., Karran E.H., Turner A.J. Membrane protein secretases. Biochem. J. 321:1997;265-279.
14. La Fleur M., Underwood J.L., Rappolee D.A., Werb Z. Basement membrane and repair of injury to peripheral nerve: defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1. J. Exp. Med. 184:1996;2311-2326.
15. Ledeen R.W., Chakraborty G. Cytokines, signal transduction and inflammatory demyelination: review and hypothesis. Neurochem. Res. 23(3):1998;277-289.
16. Leppert D., Waubant E., Galardy R., Bunnett N.W., Hauser S.L. T cell gelatinases mediate basement membrane transmigration in vitro. J. Immunol. 154:1995;4379-4389.
17. McGeehan G.M., Becherer J.D., Bast R.C., Boyer C.M., Champion B., Connolly K.M., Conway J.G., Furdon P., Karp S., Kidao S., McElroy A.B., Nichols J., Pryzwansky K.M., Schoenen F., Sekut L., Truesdale A., Verghese M., Warner J., Ways J.P. Regulation of tumor necrosis factor-α processing by a metalloproteinase inhibitor. Nature. 370:1994;558-561.
18. R.R. Myers, R. Wagner, L. Sorkin, Hyperalgesic action of cytokines on the peripheral nervous system, in: Watkins (Ed.), Cytokines and Pain: Progress in Inflammation Research, Birkhausen Verlag, Basal, 1999, pp. 133-158.
19. Myers R.R., Heckman H.M., Rodriguez M. Reduced hyperalgesia in nerve-injured WLD mice: relationship to nerve fiber phagocytosis, axonal degeneration and regeneration in normal mice. Exp. Neurol. 141:1996;94-101.
20. Myers R.R., Heckman H.M., Powell H.C. Axonal viability and the persistence of thermal hyperalgesia after partial freeze lesion of nerve. J. Neurol. Sci. 139:1996;28-38.
21. Myers R.R. The pathogenesis of neuropathic pain. The 1994 ASRA Lecture. Reg. Anesth. 20:1995;173-184.
22. Myers R.R., Yamamoto T., Yaksh T.L., Powell H.C. The role of focal nerve ischemia and Wallerian degeneration in peripheral nerve injury producing hyperesthesia. Anesthesiology. 78:1993;308-316.
23. Peck R., Brockhaus M., Frey J.R. Cell surface tumor necrosis factor (TNF) accounts for monocyte- and lymphocyte-mediated killing of TNF-resistant target cells. Cell. Immunol. 122:1989;1-10.
24. Redford E.J., Hael S.M., Smith K.J. Vascular changes and demyelination induced by the intraneural injection of tumor necrosis factor. Brain. 118:1995;869-878.
25. Redford E.J., Smith K.J., Gregson N.A., Davies M., Hughes P., Gearing A.J.H., Miller K., Hughes R.A.C. A combined inhibitor of matrix metalloproteinase activity and TNF-α processing attenuates experimental autoimmune neuritis. Brain. 120:1997;1895-1905.
26. Sommer C., Schmidt C., George A., Toyka K.V. A metalloprotease-inhibitor reduces pain associated behavior in mice with experimental neuropathy. Neurosci. Lett. 237:1997;45-48.
27. Sommer C., Lalonde A., Heckman H.M., Rodriguez M., Myers R.R. Quantitative neuropathology of a focal nerve injury causing hyperalgesia. J. Neuropathol. Exp. Neurol. 54:1995;635-643.
28. Towbin J., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrilamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U. S. A. 76:1979;4350-4354.
29. Wagner R., Myers R.R. Schwann cells produce TNF-alpha: expression in injured and non-injured nerves. Neuroscience. 73(3):1996;625-629.
30. Wagner R., Myers R.R. Endoneurial injection of TNF-alpha produces neuropathic pain behaviors. NeuroReport. 7(18):1996;2897-2901.
31. R. Wagner, R.R. Myers, Mechanisms and management of neuropathic pain, in: S.E. Abram (Ed.), Atlas of Anesthesia, Pain Management, Vol. VI, Chap. 3, Philadelphia, 1998.
32. Williams L.M., Gibbons D.L., Gearing A., Maini R.N., Feldman M., Brennan F.M. Paradoxical effects of synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNF processing in RA synovial membrane cell cultures. J. Clin. Invest. 97(12):1996;2833-2841.
33. Woessner J.F. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5:1991;2145-2154.
34. Yong V.W., Krekoski C.A., Forsyth P.A., Bell R., Edwards D.R. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci. 21(2):1998;75-80.